Category Archives: Health

Latest From Health

Breast Cancer and Biotechnology: Bigger Than Pink

lori_thumb

By David Welch, President/Senior Producer at M2 MultiMedia It had been five years since I produced Biotechnology: Knowledge Serving Life, a video that featured breast cancer patient Lori Lober and her then five year anniversary of being cancer free.  Diagnosed with Stage IV metastatic breast cancer in 2000 Lori had been admitted to an advanced clinical trial for a promising new biologic. Today, Lori credits her treatment for helping to save her life. During the Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , ,

Repositioning Drugs for Parkinson’s Disease

Parkinson's Research

Last month, The Michael J. Fox Foundation (MJFF) announced the launch of its Repositioning Drugs for PD 2012 program. The program follows a successful 2011 during which the Foundation funded nine awards totaling $3.4 million repositioning existing drugs that could benefit Parkinson’s disease patients. The program seeks projects that will test drugs that are either already FDA-approved or that have been proven safe in a clinical trial for a certain indication, to determine whether the Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , ,

Resistance is Futile – SuperDrugs for SuperBugs

800px-Acinetobacter_baumannii

“MRSA’s kill 100,000 people a year, more than AIDS,” said Mark Leuchetenberger, President and CEO, Rib-X Pharmaceuticals, Inc. With new superbugs on the rise and new superdrugs continuing to decline, the antibacterial drug discovery market is anyone’s for the taking. Attendees of the 10th Annual BIO Investor Forum participating in the Infectious Disease Therapeutic Workshop heard from an engaging panel that seemed to agree the economics of this category are driven by two things: society expects Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , , ,

Developing Cancer Therapies and Diagnostics: 4 Pieces of Advice

oncology

Insights in to the molecular and genetic basis of disease are driving new product and therapeutic opportunities while changing the treatment paradigm for many cancers. The use of companion diagnostics in oncology may play a role in optimizing and expediting the development of targeted therapies for many cancers and other conditions. Focusing on these new markets, a panel of industry executives and investors at the 2011 BIO Investor Forum discussed some of the most compelling Read More >

Health  |  1 Comment  |  Email This Post
Tags: , , , , , , ,

Ten Years After 9/11 and the Anthrax Attacks

Bacillus anthracis

Yesterday, the U.S. Senate Committee on Homeland Security and Governmental Affairs held a hearing entitled, “Ten Years After 9/11 and the Anthrax Attacks: Protecting Against Biological Threats”. As stated by Chairman Lieberman in his opening remarks, the goal of the hearing was to examine whether the federal government “has developed the tools we need to respond effectively to a bioterror attack or naturally-occurring pandemic disease, to develop and disseminate vaccines and antibiotics, and to respond Read More >

Health, Public Policy  |  Leave a comment  |  Email This Post
Tags: , , , , , ,